...
首页> 外文期刊>Genetics in medicine >Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement
【24h】

Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement

机译:临床全面测序成本效益的前瞻性比较,常规护理压倒性地支持早期使用和偿还

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: To undertake the first prospective cost-effectiveness study of whole-exome sequencing (WES) as an early, routine clinical test for infants with suspected monogenic disorders.
机译:目的:承接全外膜测序(WES)的第一次预期成本效益研究,作为婴儿患有可疑的单一疾病的婴儿的早期常规临床试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号